{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,3]],"date-time":"2026-08-03T15:03:37Z","timestamp":1785769417306,"version":"3.56.0"},"reference-count":59,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2024,11,14]],"date-time":"2024-11-14T00:00:00Z","timestamp":1731542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,11,14]],"date-time":"2024-11-14T00:00:00Z","timestamp":1731542400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100001807","name":"Funda\u00e7\u00e3o de Amparo \u00e0 Pesquisa do Estado de S\u00e3o Paulo","doi-asserted-by":"publisher","award":["#2018\/07366-4; #2022\/14820-9; #2020\/02109-3; #2022\/14846-8;"],"award-info":[{"award-number":["#2018\/07366-4; #2022\/14820-9; #2020\/02109-3; #2022\/14846-8;"]}],"id":[{"id":"10.13039\/501100001807","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001807","name":"Funda\u00e7\u00e3o de Amparo \u00e0 Pesquisa do Estado de S\u00e3o Paulo","doi-asserted-by":"publisher","award":["#2018\/07366-4; #2022\/14820-9; #2020\/02109-3; #2022\/14846-8;"],"award-info":[{"award-number":["#2018\/07366-4; #2022\/14820-9; #2020\/02109-3; #2022\/14846-8;"]}],"id":[{"id":"10.13039\/501100001807","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001807","name":"Funda\u00e7\u00e3o de Amparo \u00e0 Pesquisa do Estado de S\u00e3o Paulo","doi-asserted-by":"publisher","award":["#2018\/07366-4; #2022\/14820-9; #2020\/02109-3; #2022\/14846-8;"],"award-info":[{"award-number":["#2018\/07366-4; #2022\/14820-9; #2020\/02109-3; #2022\/14846-8;"]}],"id":[{"id":"10.13039\/501100001807","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002322","name":"Coordena\u00e7\u00e3o de Aperfei\u00e7oamento de Pessoal de N\u00edvel Superior","doi-asserted-by":"publisher","award":["001"],"award-info":[{"award-number":["001"]}],"id":[{"id":"10.13039\/501100002322","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002322","name":"Coordena\u00e7\u00e3o de Aperfei\u00e7oamento de Pessoal de N\u00edvel Superior","doi-asserted-by":"publisher","award":["001"],"award-info":[{"award-number":["001"]}],"id":[{"id":"10.13039\/501100002322","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003593","name":"Conselho Nacional de Desenvolvimento Cient\u00edfico e Tecnol\u00f3gico","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003593","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Neurobiol"],"published-print":{"date-parts":[[2025,4]]},"DOI":"10.1007\/s12035-024-04611-9","type":"journal-article","created":{"date-parts":[[2024,11,14]],"date-time":"2024-11-14T14:44:00Z","timestamp":1731595440000},"page":"5333-5346","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Deletion of the Transient Receptor Potential Melastatin 2 Gene Mitigates the 6-Hydroxydopamine-Induced Parkinson\u2019s Disease\u2013Like Pathology"],"prefix":"10.1007","volume":"62","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4096-9911","authenticated-orcid":false,"given":"Ana Flavia F.","family":"Ferreira","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2114-3815","authenticated-orcid":false,"given":"Henning","family":"Ulrich","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7180-1938","authenticated-orcid":false,"given":"Yasuo","family":"Mori","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2454-4462","authenticated-orcid":false,"given":"Zhong-Ping","family":"Feng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5142-1874","authenticated-orcid":false,"given":"Hong-Shuo","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0563-0645","authenticated-orcid":false,"given":"Luiz Roberto","family":"Britto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,11,14]]},"reference":[{"issue":"19","key":"4611_CR1","doi-asserted-by":"publisher","first-page":"3657","DOI":"10.1111\/febs.14607","volume":"285","author":"DJ Surmeier","year":"2018","unstructured":"Surmeier DJ (2018) Determinants of dopaminergic neuron loss in Parkinson\u2019s disease. FEBS J 285(19):3657\u201368. https:\/\/doi.org\/10.1111\/febs.14607","journal-title":"FEBS J"},{"issue":"10291","key":"4611_CR2","doi-asserted-by":"publisher","first-page":"2284","DOI":"10.1016\/S0140-6736(21)00218-X","volume":"397","author":"BR Bloem","year":"2021","unstructured":"Bloem BR, Okun MS, Klein C (2021) Parkinson\u2019s disease. Lancet 397(10291):2284\u2013303. https:\/\/doi.org\/10.1016\/S0140-6736(21)00218-X","journal-title":"Lancet"},{"issue":"9","key":"4611_CR3","first-page":"1264","volume":"32","author":"JA Obeso","year":"2018","unstructured":"Obeso JA, Stamelou M, Goetz CG, Poewe W, Lang AE, Weintraub D et al (2018) HHS Public Access 32(9):1264\u20131310","journal-title":"HHS Public Access"},{"issue":"1","key":"4611_CR4","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/978-94-007-5416-4_16","volume":"3","author":"W Poewe","year":"2017","unstructured":"Poewe W, Seppi K, Tanner CM, Halliday GM, Brundin P, Volkmann J et al (2017) Parkinson disease. Nat Rev Dis Prim 3(1):1\u201321. https:\/\/doi.org\/10.1007\/978-94-007-5416-4_16","journal-title":"Nat Rev Dis Prim"},{"issue":"1","key":"4611_CR5","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1111\/ene.14108","volume":"27","author":"R Balestrino","year":"2020","unstructured":"Balestrino R, Schapira AHV (2020) Parkinson disease. Eur J Neurol 27(1):27\u201342","journal-title":"Eur J Neurol"},{"issue":"5","key":"4611_CR6","doi-asserted-by":"publisher","first-page":"459","DOI":"10.1016\/S1474-4422(18)30499-X","volume":"18","author":"VL Feigin","year":"2019","unstructured":"Feigin VL, Nichols E, Alam T, Bannick MS, Beghi E, Blake N et al (2019) Global, regional, and national burden of neurological disorders, 1990\u20132016: a systematic analysis for the Global Burden of Disease Study 2016. Lancet Neurol 18(5):459\u2013480","journal-title":"Lancet Neurol"},{"key":"4611_CR7","doi-asserted-by":"publisher","unstructured":"Ou Z, Pan J, Tang S, Duan D, Yu D, Nong H,\u00a0Wang Z (2021) Global trends in the incidence, prevalence, and years lived with disability of Parkinson\u2019s disease in 204 countries\/territories from 1990 to 2019. Front Public Heal 9(December).\u00a0https:\/\/doi.org\/10.3389\/fpubh.2021.776847","DOI":"10.3389\/fpubh.2021.776847"},{"key":"4611_CR8","doi-asserted-by":"publisher","unstructured":"Pereira GM, Teixeira-dos-Santos D, Soares NM, Marconi GA, Friedrich DC, Saffie Awad P,\u00a0Santos-Lobato BL,\u00a0Brand\u00e3o PRP, Noyce AJ, Marras C, Mata IF, Rieder CRdeM, Schuh AFS (2024) A systematic review and meta-analysis of the prevalence of Parkinson\u2019s disease in lower to upper-middle-income countries. Npj Park Dis 10(1):181.\u00a0https:\/\/doi.org\/10.1038\/s41531-024-00779-y","DOI":"10.1038\/s41531-024-00779-y"},{"issue":"6","key":"4611_CR9","doi-asserted-by":"publisher","first-page":"800","DOI":"10.1002\/mds.20806","volume":"21","author":"MT Barbosa","year":"2006","unstructured":"Barbosa MT, Caramelli P, Maia DP, Cunningham MCQ, Guerra HL, Lima-Costa MF et al (2006) Parkinsonism and Parkinson\u2019s disease in the elderly: a community-based survey in Brazil (the Bambu\u00ed study). Mov Disord [Internet]. 21(6):800\u20138. https:\/\/doi.org\/10.1002\/mds.20806","journal-title":"Mov Disord [Internet]."},{"issue":"8 August","key":"4611_CR10","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1371\/journal.pone.0237472","volume":"15","author":"JY Hong","year":"2020","unstructured":"Hong JY, Sunwoo MK, Yoon JH, Kang SY, Sohn YH, Lee PH et al (2020) Rapid drug increase and early onset of levodopa-induced dyskinesia in Parkinson\u2019s disease. PLoS One 15(8 August):1\u20139. https:\/\/doi.org\/10.1371\/journal.pone.0237472","journal-title":"PLoS One"},{"issue":"1","key":"4611_CR11","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41598-020-79110-7","volume":"11","author":"A Luca","year":"2021","unstructured":"Luca A, Monastero R, Baschi R, Cicero CE, Mostile G, Dav\u00ec M et al (2021) Cognitive impairment and levodopa induced dyskinesia in Parkinson\u2019s disease: a longitudinal study from the PACOS cohort. Sci Rep 11(1):1\u20137. https:\/\/doi.org\/10.1038\/s41598-020-79110-7","journal-title":"Sci Rep"},{"key":"4611_CR12","doi-asserted-by":"publisher","first-page":"114664","DOI":"10.1016\/j.bcp.2021.114664","volume":"190","author":"R Shi","year":"2021","unstructured":"Shi R, Fu Y, Zhao D, Boczek T, Wang W, Guo F (2021) Cell death modulation by transient receptor potential melastatin channels TRPM2 and TRPM7 and their underlying molecular mechanisms. Biochem Pharmacol 190:114664","journal-title":"Biochem Pharmacol"},{"issue":"1 55-1","key":"4611_CR13","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1152\/ajpcell.00331.2003","volume":"286","author":"R Kraft","year":"2004","unstructured":"Kraft R, Grimm C, Grosse K, Hoffmann A, Sauerbruch S, Kettenmann H et al (2004) Hydrogen peroxide and ADP-ribose induce TRPM2-mediated calcium influx and cation currents in microglia. Am J Physiol - Cell Physiol 286(1 55-1):129\u201337","journal-title":"Am J Physiol - Cell Physiol"},{"issue":"1","key":"4611_CR14","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1254\/jphs.FP0060128","volume":"101","author":"S Kaneko","year":"2006","unstructured":"Kaneko S, Kawakami S, Hara Y, Wakamori M, Itoh E, Minami T et al (2006) A critical role of TRPM2 in neuronal cell death by hydrogen peroxide. J Pharmacol Sci 101(1):66\u201376","journal-title":"J Pharmacol Sci"},{"key":"4611_CR15","doi-asserted-by":"publisher","unstructured":"Bond CE, Greenfield SA (2007) Multiple cascade effects of oxidative stress on astroglia. Glia 55(13):1348\u20131361.\u00a0https:\/\/doi.org\/10.1002\/glia.20547","DOI":"10.1002\/glia.20547"},{"issue":"7","key":"4611_CR16","doi-asserted-by":"publisher","first-page":"2533","DOI":"10.1096\/fj.09-149997","volume":"24","author":"M Lee","year":"2010","unstructured":"Lee M, Cho T, Jantaratnotai N, Wang YT, McGeer E, McGeer PL (2010) Depletion of GSH in glial cells induces neurotoxicity: relevance to aging and degenerative neurological diseases. FASEB J 24(7):2533\u20132545","journal-title":"FASEB J"},{"issue":"616","key":"4611_CR17","first-page":"1","volume":"85","author":"Y Huang","year":"2020","unstructured":"Huang Y, Fliegert R, Guse AH, L\u00fc W, Du J (2020) A structural overview of the ion channels of the TRPM family. Cell Calcium 85(616):1\u201325","journal-title":"Cell Calcium"},{"key":"4611_CR18","doi-asserted-by":"publisher","unstructured":"Szollosi A (2021) Two decades of evolution of our understanding of the transient receptor potential melastatin 2 (Trpm2) cation channel. Life 11(5).\u00a0https:\/\/doi.org\/10.3390\/life11050397","DOI":"10.3390\/life11050397"},{"key":"4611_CR19","doi-asserted-by":"publisher","unstructured":"Feng Z (2017) TRPM2 a potential drug target to retard oxidative stress. Front Biosci 22(9):4551.\u00a0https:\/\/doi.org\/10.2741\/4551","DOI":"10.2741\/4551"},{"issue":"1","key":"4611_CR20","doi-asserted-by":"publisher","first-page":"1","DOI":"10.36922\/an.v1i1.3","volume":"1","author":"J Steinman","year":"2022","unstructured":"Steinman J, Ovcjak A, Luo Z, Zhang X, Britto LR, Henderson JT et al (2022) Transient receptor potential melastatin 2 channels in neurological disorders: mechanisms and animal models. Adv Neurol 1(1):1\u201318","journal-title":"Adv Neurol"},{"key":"4611_CR21","doi-asserted-by":"publisher","unstructured":"Ferreira AF, Britto LG (2023) The transient receptor potential melastatin 2: a new therapeutical target for Parkinson\u2032s disease? Neural Regen Res [Internet] 18(8):0 https:\/\/doi.org\/10.4103\/1673-5374.360343","DOI":"10.4103\/1673-5374.360343"},{"issue":"1","key":"4611_CR22","doi-asserted-by":"publisher","first-page":"409","DOI":"10.1007\/s12035-016-0338-9","volume":"55","author":"Y Sun","year":"2018","unstructured":"Sun Y, Sukumaran P, Selvaraj S, Cilz NI, Schaar A, Lei S et al (2018) TRPM2 promotes neurotoxin MPP+\/MPTP-Induced cell death. Mol Neurobiol 55(1):409\u201320. https:\/\/doi.org\/10.1007\/s12035-016-0338-9","journal-title":"Mol Neurobiol"},{"issue":"12","key":"4611_CR23","doi-asserted-by":"publisher","first-page":"782","DOI":"10.9734\/AIR\/2014\/10543","volume":"2","author":"YP Yu","year":"2014","unstructured":"Yu YP (2014) TrkA pathway(s) are involves in the regulation of TRPM2 and TRPM7 expression in the substantia nigra of the Parkinson\u2019s disease rat model induced by 6-hydroxydopamine. Adv Res 2(12):782\u201396","journal-title":"Adv Res"},{"issue":"3","key":"4611_CR24","doi-asserted-by":"publisher","first-page":"1543","DOI":"10.1007\/s12035-022-02723-8","volume":"59","author":"AFF Ferreira","year":"2022","unstructured":"Ferreira AFF, Singulani MP, Ulrich H, Feng ZP, Sun HS, Britto LR (2022) Inhibition of TRPM2 by AG490 is neuroprotective in a Parkinson\u2019s disease animal model. Mol Neurobiol 59(3):1543\u201359. https:\/\/doi.org\/10.1007\/s12035-022-02723-8","journal-title":"Mol Neurobiol"},{"issue":"March","key":"4611_CR25","doi-asserted-by":"publisher","first-page":"136","DOI":"10.1016\/j.neuro.2022.03.010","volume":"90","author":"H Tamura","year":"2022","unstructured":"Tamura H, Nishio R, Saeki N, Katahira M, Morioka H, Tamano H et al (2022) Paraquat-induced intracellular Zn2+ dysregulation causes dopaminergic degeneration in the substantia nigra, but not in the striatum. Neurotoxicology 90(March):136\u201344. https:\/\/doi.org\/10.1016\/j.neuro.2022.03.010","journal-title":"Neurotoxicology"},{"key":"4611_CR26","doi-asserted-by":"publisher","unstructured":"Ferreira AFF, Ulrich H, Feng ZP, Sun HS, Britto LR (2024) Neurodegeneration and glial morphological changes are both prevented by TRPM2 inhibition during the progression of a Parkinson\u2019s disease mouse model. Exp Neurol 377:114780.\u00a0https:\/\/doi.org\/10.1016\/j.expneurol.2024.114780","DOI":"10.1016\/j.expneurol.2024.114780"},{"issue":"3","key":"4611_CR27","doi-asserted-by":"publisher","first-page":"1528","DOI":"10.1007\/s12035-021-02711-4","volume":"59","author":"B Vaidya","year":"2022","unstructured":"Vaidya B, Kaur H, Thapak P, Sharma SS, Singh JN (2022) Pharmacological modulation of TRPM2 channels via PARP pathway leads to neuroprotection in mptp-induced Parkinson\u2019s disease in Sprague Dawley rats. Mol Neurobiol 59(3):1528\u201342. https:\/\/doi.org\/10.1007\/s12035-021-02711-4","journal-title":"Mol Neurobiol"},{"issue":"7","key":"4611_CR28","doi-asserted-by":"publisher","first-page":"738","DOI":"10.1038\/nm1758","volume":"14","author":"S Yamamoto","year":"2008","unstructured":"Yamamoto S, Shimizu S, Kiyonaka S, Takahashi N, Wajima T, Hara Y et al (2008) TRPM2-mediated Ca2+ influx induces chemokine production in monocytes that aggravates inflammatory neutrophil infiltration. Nat Med 14(7):738\u2013747","journal-title":"Nat Med"},{"issue":"11","key":"4611_CR29","doi-asserted-by":"publisher","first-page":"3931","DOI":"10.1523\/JNEUROSCI.4703-11.2012","volume":"32","author":"K Haraguchi","year":"2012","unstructured":"Haraguchi K, Kawamoto A, Isami K, Maeda S, Kusano A, Asakura K et al (2012) TRPM2 contributes to inflammatory and neuropathic pain through the aggravation of pronociceptive inflammatory responses in mice. J Neurosci 32(11):3931\u20133941","journal-title":"J Neurosci"},{"issue":"45","key":"4611_CR30","doi-asserted-by":"publisher","first-page":"15157","DOI":"10.1523\/JNEUROSCI.4081-14.2015","volume":"35","author":"VG Ostapchenko","year":"2015","unstructured":"Ostapchenko VG, Chen M, Guzman MS, Xie YF, Lavine N, Fan J et al (2015) The transient receptor potential melastatin 2 (TRPM2) channel contributes to \u03b2-amyloid oligomer-related neurotoxicity and memory impairment. J Neurosci 35(45):15157\u201315169","journal-title":"J Neurosci"},{"issue":"39","key":"4611_CR31","doi-asserted-by":"publisher","first-page":"8484","DOI":"10.1523\/JNEUROSCI.2203-17.2018","volume":"38","author":"M Tsutsui","year":"2018","unstructured":"Tsutsui M, Hirase R, Miyamura S, Nagayasu K, Nakagawa T, Mori Y et al (2018) TRPM2 exacerbates central nervous system inflammation in experimental autoimmune encephalomyelitis by increasing production of CXCL2 chemokines. J Neurosci 38(39):8484\u20138495","journal-title":"J Neurosci"},{"issue":"11","key":"4611_CR32","doi-asserted-by":"publisher","first-page":"e1541","DOI":"10.1038\/cddis.2014.494","volume":"5","author":"M Ye","year":"2014","unstructured":"Ye M, Yang W, Ainscough JF, Hu XP, Li X, Sedo A et al (2014) TRPM2 channel deficiency prevents delayed cytosolic Zn2+ accumulation and CA1 pyramidal neuronal death after transient global ischemia. Cell Death Dis 5(11):e1541","journal-title":"Cell Death Dis"},{"key":"4611_CR33","doi-asserted-by":"publisher","unstructured":"Huang S, Turlova E, Li F, Bao M hua hua, Szeto V, Wong R, et al (2017) Transient receptor potential melastatin 2 channels (TRPM2) mediate neonatal hypoxic-ischemic brain injury in mice. Exp Neurol 296:32\u201340. https:\/\/doi.org\/10.1016\/j.expneurol.2017.06.023","DOI":"10.1016\/j.expneurol.2017.06.023"},{"key":"4611_CR34","doi-asserted-by":"publisher","unstructured":"Clayton JA, Collins FS (2014) Policy: NIH to balance sex in cell and animal studies. Nature 509(7500):282\u2013283.\u00a0https:\/\/doi.org\/10.1038\/509282a","DOI":"10.1038\/509282a"},{"issue":"1","key":"4611_CR35","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1186\/s13293-023-00511-0","volume":"14","author":"L Karlsson Lind","year":"2023","unstructured":"Karlsson Lind L, Rydberg DM, Schenck-Gustafsson K (2023) Sex and gender differences in drug treatment: experiences from the knowledge database Janusmed Sex and Gender. Biol Sex Differ 14(1):28. https:\/\/doi.org\/10.1186\/s13293-023-00511-0","journal-title":"Biol Sex Differ"},{"key":"4611_CR36","doi-asserted-by":"publisher","unstructured":"Zucker I, Prendergast BJ (2020) Sex differences in pharmacokinetics predict adverse drug reactions in women. Biol Sex Differ 11(1):32.\u00a0https:\/\/doi.org\/10.1186\/s13293-020-00308-5","DOI":"10.1186\/s13293-020-00308-5"},{"key":"4611_CR37","doi-asserted-by":"publisher","unstructured":"Real CC, Binda KH, Thomsen MB, Lillethorup TP, Brooks DJ, Landau AM (2023) Selecting the best animal model of Parkinson\u2019s disease for your research purpose: insight from in vivo PET imaging studies. Curr Neuropharmacol 21(5):1241\u20131272.\u00a0https:\/\/doi.org\/10.2174\/1570159X21666230216101659","DOI":"10.2174\/1570159X21666230216101659"},{"key":"4611_CR38","doi-asserted-by":"publisher","unstructured":"Ortelli P, Ferrazzoli D, Zarucchi M, Maestri R, Frazzitta G (2018) Asymmetric dopaminergic degeneration and attentional resources in Parkinson\u2019s disease. Front Neurosci 12.\u00a0https:\/\/doi.org\/10.3389\/fnins.2018.00972","DOI":"10.3389\/fnins.2018.00972"},{"key":"4611_CR39","unstructured":"Paxinos G, Franklin KBJ (2019) Paxinos and Franklin\u2019s the mouse brain in stereotaxic coordinates.\u00a0Academic press"},{"key":"4611_CR40","doi-asserted-by":"publisher","unstructured":"Cho C, Michailidis V, Lecker I, Collymore C, Hanwell D, Loka M,\u00a0Danesh M, Pham C,\u00a0Urban P, Bonin RP, Martin LJ (2019) Evaluating analgesic efficacy and administration route following craniotomy in mice using the grimace scale. Sci Rep 9(1):359.\u00a0https:\/\/doi.org\/10.1038\/s41598-018-36897-w","DOI":"10.1038\/s41598-018-36897-w"},{"issue":"November 2019","key":"4611_CR41","doi-asserted-by":"publisher","first-page":"146521","DOI":"10.1016\/j.brainres.2019.146521","volume":"1727","author":"KH Binda","year":"2020","unstructured":"Binda KH, Real CC, Ferreira AFF, Britto LR, Chacur M (2020) Antinociceptive effects of treadmill exercise in a rat model of Parkinson\u2019s disease: the role of cannabinoid and opioid receptors. Brain Res [Internet]. 1727(November 2019):146521. https:\/\/doi.org\/10.1016\/j.brainres.2019.146521","journal-title":"Brain Res [Internet]."},{"issue":"December 2019","key":"4611_CR42","doi-asserted-by":"publisher","first-page":"112607","DOI":"10.1016\/j.bbr.2020.112607","volume":"387","author":"AFF Ferreira","year":"2020","unstructured":"Ferreira AFF, Binda KH, Singulani MP, Pereira CPM, Ferrari GD, Alberici LC et al (2020) Physical exercise protects against mitochondria alterations in the 6-hidroxydopamine rat model of Parkinson\u2019s disease. Behav Brain Res 387(December 2019):112607. https:\/\/doi.org\/10.1016\/j.bbr.2020.112607","journal-title":"Behav Brain Res"},{"key":"4611_CR43","doi-asserted-by":"publisher","unstructured":"Matsuura K, Kabuto H, Makino H, Ogawa N (1997) Pole test is a useful method for evaluating the mouse movement disorder caused by striatal dopamine depletion. J Neurosci Methods 73(1):45\u201348.\u00a0https:\/\/doi.org\/10.1016\/S0165-0270(96)02211-X","DOI":"10.1016\/S0165-0270(96)02211-X"},{"key":"4611_CR44","doi-asserted-by":"publisher","unstructured":"Pereira CPM, Francis-Oliveira J, Singulani MP, Ferreira AFF, Britto LRG (2023) Microglial depletion exacerbates motor impairment and dopaminergic neuron loss in a 6-OHDA model of Parkinson\u2019s disease. J Neuroimmunol 375. https:\/\/doi.org\/10.1016\/j.jneuroim.2023.578019","DOI":"10.1016\/j.jneuroim.2023.578019"},{"key":"4611_CR45","doi-asserted-by":"publisher","unstructured":"Ye P, Fang Q, Hu X, Zou W, Huang M, Ke M et al (2023) TRPM2 as a conserved gatekeeper determines the vulnerability of DA neurons by mediating ROS sensing and calcium dyshomeostasis. Prog Neurobiol [Internet]. (September):102530. Available from: https:\/\/doi.org\/10.1016\/j.pneurobio.2023.102530","DOI":"10.1016\/j.pneurobio.2023.102530"},{"key":"4611_CR46","doi-asserted-by":"publisher","unstructured":"Zou J, Ainscough JF, Yang W, Sedo A, Yu SP, Mei ZZ et al (2013) A differential role of macrophage TRPM2 channels in Ca 2+ signaling and cell death in early responses to H 2 O 2. Am J Physiol Physiol [Internet]. 305(1):C61\u20139. Available from: https:\/\/www.physiology.org\/doi\/https:\/\/doi.org\/10.1152\/ajpcell.00390.2012","DOI":"10.1152\/ajpcell.00390.2012"},{"issue":"1","key":"4611_CR47","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1007\/s12031-013-0005-9","volume":"51","author":"S Nakayama","year":"2013","unstructured":"Nakayama S, Vest R, Traystman RJ, Herson PS (2013) Sexually dimorphic response of TRPM2 inhibition following cardiac arrest-induced global cerebral ischemia in mice. J Mol Neurosci 51(1):92\u201398","journal-title":"J Mol Neurosci"},{"issue":"10","key":"4611_CR48","doi-asserted-by":"publisher","first-page":"1549","DOI":"10.1038\/jcbfm.2013.105","volume":"33","author":"T Shimizu","year":"2013","unstructured":"Shimizu T, MacEy TA, Quillinan N, Klawitter J, Perraud ALL, Traystman RJ et al (2013) Androgen and PARP-1 regulation of TRPM2 channels after ischemic injury. J Cereb Blood Flow Metab 33(10):1549\u20131555","journal-title":"J Cereb Blood Flow Metab"},{"key":"4611_CR49","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1016\/j.expneurol.2015.10.014","volume":"275","author":"K Shimizu","year":"2016","unstructured":"Shimizu K, Quillinan N, Orfila JE, Herson PS (2016) Sirtuin-2 mediates male specific neuronal injury following experimental cardiac arrest through activation of TRPM2 ion channels. Exp Neurol 275:78\u201383","journal-title":"Exp Neurol"},{"key":"4611_CR50","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1016\/j.expneurol.2016.06.015","volume":"283","author":"T Shimizu","year":"2016","unstructured":"Shimizu T, Dietz RM, Cruz-Torres I, Strnad F, Garske AK, Moreno M et al (2016) Extended therapeutic window of a novel peptide inhibitor of TRPM2 channels following focal cerebral ischemia. Exp Neurol 283:151\u20136. https:\/\/doi.org\/10.1016\/j.expneurol.2016.06.015","journal-title":"Exp Neurol"},{"issue":"1","key":"4611_CR51","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1523\/ENEURO.0022-14.2014","volume":"1","author":"N Quillinan","year":"2014","unstructured":"Quillinan N, Grewal H, Klawitter J, Herson PS (2014) Sex steroids do not modulate TRPM2-mediated injury in females following middle cerebral artery occlusion. eNeuro 1(1):1\u20138","journal-title":"eNeuro"},{"key":"4611_CR52","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2021\/8774663","volume":"2021","author":"RM Dietz","year":"2021","unstructured":"Dietz RM, Orfila JE, Chalmers N, Minjarez C, Vigil J, Deng G et al (2021) Functional restoration following global cerebral ischemia in juvenile mice following inhibition of transient receptor potential M2 (TRPM2) ion channels. Neural Plast 2021:1\u201310","journal-title":"Neural Plast"},{"issue":"11","key":"4611_CR53","doi-asserted-by":"publisher","first-page":"2160","DOI":"10.1038\/jcbfm.2011.77","volume":"31","author":"J Jia","year":"2011","unstructured":"Jia J, Verma S, Nakayama S, Quillinan N, Grafe MR, Hurn PD et al (2011) Sex differences in neuroprotection provided by inhibition of TRPM2 channels following experimental stroke. J Cereb Blood Flow Metab 31(11):2160\u20132168","journal-title":"J Cereb Blood Flow Metab"},{"issue":"3","key":"4611_CR54","doi-asserted-by":"publisher","first-page":"370","DOI":"10.1016\/j.yfrne.2014.02.002","volume":"35","author":"GE Gillies","year":"2014","unstructured":"Gillies GE, Pienaar IS, Vohra S, Qamhawi Z (2014) Sex differences in Parkinson\u2019s disease. Front Neuroendocrinol 35(3):370\u201384. https:\/\/doi.org\/10.1016\/j.yfrne.2014.02.002","journal-title":"Front Neuroendocrinol"},{"issue":"2","key":"4611_CR55","doi-asserted-by":"publisher","first-page":"152","DOI":"10.3390\/ph16020152","volume":"16","author":"A Isenbrandt","year":"2023","unstructured":"Isenbrandt A, Coulombe K, Morissette M, Bourque M, Lamontagne-Proulx J, Di Paolo T et al (2023) Three-dimensional analysis of sex- and gonadal status- dependent microglial activation in a mouse model of Parkinson\u2019s disease. Pharmaceuticals 16(2):152","journal-title":"Pharmaceuticals"},{"key":"4611_CR56","doi-asserted-by":"publisher","unstructured":"Karlsson M, Zhang C, M\u00e9ar L, Zhong W, Digre A, Katona B et al (2021) A single\u2013cell type transcriptomics map of human tissues. Sci Adv [Internet]. 7(31). Available from: https:\/\/www.science.orghttps:\/\/doi.org\/10.1126\/sciadv.abh2169","DOI":"10.1126\/sciadv.abh2169"},{"key":"4611_CR57","unstructured":"Human Protein Atlas (n.d.) Tissue expression of TRPM2 [Internet]. [cited 2024 Apr 7]. Available from: https:\/\/www.proteinatlas.org\/ENSG00000142185-TRPM2\/tissue.\u00a0Accessed 7 Jan 2024"},{"key":"4611_CR58","doi-asserted-by":"publisher","unstructured":"Beurel E, Jope RS (2006) The paradoxical pro- and anti-apoptotic actions of GSK3 in the intrinsic and extrinsic apoptosis signaling pathways. Prog Neurobiol 79(4):173\u2013189.\u00a0https:\/\/doi.org\/10.1016\/j.pneurobio.2006.07.006","DOI":"10.1016\/j.pneurobio.2006.07.006"},{"issue":"12","key":"4611_CR59","doi-asserted-by":"publisher","first-page":"8109","DOI":"10.1007\/s12035-019-01656-z","volume":"56","author":"F Li","year":"2019","unstructured":"Li F, Wong R, Luo Z, Du L, Turlova E, Britto LRG et al (2019) Neuroprotective effects of AG490 in neonatal hypoxic-ischemic brain injury. Mol Neurobiol 56(12):8109\u201323. https:\/\/doi.org\/10.1007\/s12035-019-01656-z","journal-title":"Mol Neurobiol"}],"container-title":["Molecular Neurobiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12035-024-04611-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12035-024-04611-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12035-024-04611-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,3,4]],"date-time":"2025-03-04T10:11:39Z","timestamp":1741083099000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12035-024-04611-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,11,14]]},"references-count":59,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2025,4]]}},"alternative-id":["4611"],"URL":"https:\/\/doi.org\/10.1007\/s12035-024-04611-9","relation":{},"ISSN":["0893-7648","1559-1182"],"issn-type":[{"value":"0893-7648","type":"print"},{"value":"1559-1182","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,11,14]]},"assertion":[{"value":"9 January 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 November 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 November 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All animal experiments were approved by the Ethics Committee for Animal Research of the Institute of Biomedical Sciences of the University of S\u00e3o Paulo (CEUA-ICB\/USP, Brazil, protocol number: 8395080450).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Animal Ethics"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to Participate"}},{"value":"Not applicable.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for Publication"}},{"value":"The authors declare no competing interests.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing Interests"}}]}}